Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
This study has been completed.
Study NCT00526812. Last updated on December 19, 2008.
Information provided by Reata Pharmaceuticals, Inc.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glioma
Additional conditions recognized in this trial
Oligodendroglioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Interventions listed in this trial
RTA 744
RTA 744 injection
Sponsors listed in this trial
Reata Pharmaceuticals, Inc.
Back to top of Main Content